These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6534426)

  • 21. Observations on surgical management of carcinoma of prostate with limited nodal metastases.
    Zincke H; Utz DC
    Urology; 1984 Aug; 24(2):137-45. PubMed ID: 6464250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Objective treatment response to endocrine therapy in metastatic prostate cancer.
    Zaragoza MR; Grossman HB
    Urology; 1992 Nov; 40(5):405-8. PubMed ID: 1441036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
    Goldstein J; Even-Sapir E; Ben-Haim S; Saad A; Spieler B; Davidson T; Berger R; Weiss I; Appel S; Lawrence YR; Symon Z
    Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose.
    Shreve PD; Grossman HB; Gross MD; Wahl RL
    Radiology; 1996 Jun; 199(3):751-6. PubMed ID: 8638000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The incidence of regional lymph node metastases in operable prostatic carcinoma (author's transl)].
    Kastendieck H; Bressel M; Henke A; Hüsselmann H
    Dtsch Med Wochenschr; 1980 Sep; 105(39):1348-54. PubMed ID: 7460782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Early results following radical prostatectomy in patients with capsule invasion, seminal vesicle infiltration and micrometastases].
    Terhorst B; Friedrichs R
    Urologe A; 1990 Mar; 29(2):91-5. PubMed ID: 2330669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clear cell sarcoma of soft tissue: a retrospective review and analysis of 31 cases treated at Istituto Ortopedico Rizzoli.
    Bianchi G; Charoenlap C; Cocchi S; Rani N; Campagnoni S; Righi A; Frisoni T; Donati DM
    Eur J Surg Oncol; 2014 May; 40(5):505-510. PubMed ID: 24560887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroendocrine differentiation in metastatic prostatic adenocarcinoma.
    Aprikian AG; Cordon-Cardo C; Fair WR; Zhang ZF; Bazinet M; Hamdy SM; Reuter VE
    J Urol; 1994 Apr; 151(4):914-9. PubMed ID: 8126824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional lymph node metastases in patients with soft tissue sarcomas of the extremities, what are the therapeutic consequences?
    Gaakeer HA; Albus-Lutter CE; Gortzak E; Zoetmulder FA
    Eur J Surg Oncol; 1988 Apr; 14(2):151-6. PubMed ID: 3360156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of local and regional treatment on the metastatic outcome in prostatic carcinoma with pelvic lymph node involvement.
    Leibel SA; Fuks Z; Zelefsky MJ; Whitmore WF
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):7-16. PubMed ID: 8270461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery.
    Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Cheng L; Bostwick DG
    J Urol; 1999 Apr; 161(4):1233-7. PubMed ID: 10081876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resolution of bony metastases after bilateral orchiectomy for carcinoma of prostate.
    Shortliffe LD; Freiha FS
    Urology; 1981 Apr; 17(4):353-5. PubMed ID: 7222327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of pulmonary metastases in stage D2 prostate cancer patients.
    Nakamachi H; Suzuki H; Akakura K; Imamoto T; Ueda T; Ishihara M; Furuya Y; Ichikawa T; Igarashi T; Ito H
    Prostate Cancer Prostatic Dis; 2002; 5(2):159-63. PubMed ID: 12497007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is combined modality therapy appropriate for apparently localized carcinoma of the prostate?
    Fair WR; Heston WD
    Urol Clin North Am; 1991 Aug; 18(3):477-80. PubMed ID: 1877109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there a favorable subset of patients with prostate cancer who develop oligometastases?
    Singh D; Yi WS; Brasacchio RA; Muhs AG; Smudzin T; Williams JP; Messing E; Okunieff P
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):3-10. PubMed ID: 14697414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostatic adenocarcinoma metastases mimicking small cell carcinoma on fine-needle aspiration.
    Parwani AV; Ali SZ
    Diagn Cytopathol; 2002 Aug; 27(2):75-9. PubMed ID: 12203872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detecting metastatic prostate carcinoma in pelvic lymph nodes following neoadjuvant hormone therapy: the eyes have it!
    Kehr E; Masry P; Lis R; Loda M; Taplin ME; Hirsch MS
    Histopathology; 2016 Jan; 68(2):303-7. PubMed ID: 26018610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervical lymph node enlargement on the right side as the initial manifestation of metastatic prostate cancer.
    Ozgür A; Ilker Y; Türkeri LN
    Arch Esp Urol; 2003 Sep; 56(7):859-61. PubMed ID: 14595895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT.
    Cohade C; Osman M; Pannu HK; Wahl RL
    J Nucl Med; 2003 Feb; 44(2):170-6. PubMed ID: 12571205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of prostatic adenocarcinoma clinically presenting as supraclavicular and mediastinal lymphadenopathy].
    Tsujino K; Sasada S; Kawahara K; Terada H; Komori C; Suzuki H; Okamoto N; Kobayashi M; Hirashima T; Matsui K; Kawase I
    Nihon Kokyuki Gakkai Zasshi; 2007 Aug; 45(8):648-53. PubMed ID: 17763696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.